What is the Homology Medicines Inc stock price forecast?

Homology Medicines Inc is currently trading at $12.98. View real-time AI analysis on Alpha Lenz.

What is Homology Medicines Inc insider trading activity?

View the latest insider trading data for Homology Medicines Inc on Alpha Lenz.

What is Homology Medicines Inc's P/E ratio?

Homology Medicines Inc's P/E ratio is -6.6.

Homology Medicines Inc

NASDAQ · FIXX

$12.98+5.89(+83.06%)Pre-market

Ask about Homology Medicines Inc's future dividend policy...

Alpha Chat Insight

“Homology Medicines Inc trades at a P/E of -6.6 (undervalued) with modest ROE of -90.0%.”

Ask for details →

Company Overview

Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases in the United States. The company offers proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a nuclease-free gene editing mobility, gene therapy or for various genetic disorders. Its earlier stage product candidates comprising HMI-202, an investigational gene therapy which completed IND-enabling studies for the treatment of metachromatic leukodystrophy; and HMI-104 which completed IND-enabling studies. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts.

CEODr. Albert Seymour Ph.D.

Websitehttps://www.homologymedicines.com

SectorHealthcare

IndustryBiotechnology

Employees7

Company Statistics

FY 2023

Profile

$750.64MMarket Cap

$1.16MRevenue

0.00Shares Out

7Employees

Margins

N/AGross

-7868.86%EBITDA

-7967.30%Operating

-7532.87%Pre-Tax

-9771.71%Net

Valuation

-6.65P/E

10.28P/B

649.34EV/Sales

-7.83EV/EBITDA

-7.78P/FCF

Growth (CAGR)

-24.65%Rev 3Yr

N/ARev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-72.17%ROA

-90.02%ROE

-58.84%ROIC

Financial Health

$39.27MCash & Cash Equivalents

$-27.69MNet Debt

15.86%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Homology Medicines Inc trades at a P/E of -6.6 (undervalued) with modest ROE of -90.0%.”

Ask for details →

Frequently Asked Questions

Homology Medicines Inc (ticker: FIXX) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 7 employees. Market cap is $751M.

The current price is $12.979 with a P/E ratio of -6.65x and P/B of 10.28x.

ROE is -90.02% and operating margin is -7967.30%. Annual revenue is $1M.